ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01282619
Recruitment Status : Unknown
Verified January 2011 by Shandong Luye Pharmaceutical Co., Ltd..
Recruitment status was:  Recruiting
First Posted : January 25, 2011
Last Update Posted : January 25, 2011
Sponsor:
Information provided by:
Shandong Luye Pharmaceutical Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2012
  Estimated Study Completion Date : June 2012